Skip to main content

Table 8 Antibiotic resistance in Gram-positive isolates

From: Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country

 

Frequency

Ampicillin

Amoxicillin-clavulanate

Piperacillin

Pip/Tazo

Imipenem

Meropenem

Cefuroxime

Cefotaxime

Ceftriaxone

Ceftazidime

Ciprofloxacin

Levofloxacin

Moxifloxacin

Gram-positive bacteria

34

 

 Lactobacilli

3

1 (50)

1 (50)

0

0

0

0

1 (33.3)

0

0

Corynebacteria

2

1 (50)

0

0

0

0

0

0

0

0

0

 E. fecalis

9

3 (33.3)

3 (33.3)

2 (66.7)

3 (42.9)

3 (37.5)

3 (42.9)

 MRSA

1

1 (100)

1 (100)

1 (100)

0

MSSA

1

0

0

0

0

0

 S. epidermidis

2

2 (100)

2 (100)

2 (100)

1 (100)

1 (50)

0

0

 S. hemolyticus

1

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

0

 S. cohnii

1

1 (100)

1 (100)

0

0

0

 S. capitis

1

0

0

0

0

0

 S. oralis

2

0

0

2 (100)

1 (100)

TMP/SMX

Gentamicin

Streptomycin

Amikacin

Benzylpenicillin

Oxacillin

Erythromycin

Quinupristin/Dalfopristin

Vancomycin

Tetracycline

Tigecycline

Nitrofurantoin

Linezolid

Clindamycin

Rifampicin

1 (100)

0

0

0

0

0

0

1 (100)

1 (100)

0

0

0

3 (33.3)

3 (33.3)

3 (33.3)

4 (100)

6 (66.7)

2 (22.2)

4 (50)

0

0

0

0

0

1 (100)

1 (100)

1 (100)

0

0

0

0

0

0

0

0

0

1 (100)

0

0

0

0

0

0

0

0

0

1 (50)

0

2 (100)

2 (100)

1 (50)

0

0

1 (50)

0

0

0

0

1 (100)

1 (100)

1 (100)

1 (100)

0

0

0

0

0

0

0

0

0

0

1 (100)

1 (100)

1 (100)

0

0

0

0

0

1 (100)

0

0

0

0

0

0

0

0

0

0

0

0

0

2 (100)

0

2 (100)

0

0

1 (50)

  1. E.fecalis, Enterococcus faecalis; MRSA, methicillin–resistant Staphylococcus aureus; MSSA, methicillin–sensitive Staphylococcus aureus; S. epidermidis; Staphylococcus epidermidis; S. hemolyticus, Staphylococcus hemolyticus; S. cohnii; Staphylococcus cohnii; S. capitis, Staphylococcus capitis; S. oralis, Streptococcus oralis